Cite
Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.
MLA
Costedoat-Chalumeau N, et al. “Low Blood Concentration of Hydroxychloroquine Is a Marker for and Predictor of Disease Exacerbations in Patients with Systemic Lupus Erythematosus.” Arthritis & Rheumatism, vol. 54, no. 10, Oct. 2006, pp. 3284–90. EBSCOhost, https://doi.org/10.1002/art.22156.
APA
Costedoat-Chalumeau N, Amoura Z, Hulot JS, Hammoud HA, Aymard G, Cacoub P, Francès C, Wechsler B, Huong du LT, Ghillani P, Musset L, Lechat P, & Piette JC. (2006). Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis & Rheumatism, 54(10), 3284–3290. https://doi.org/10.1002/art.22156
Chicago
Costedoat-Chalumeau N, Amoura Z, Hulot JS, Hammoud HA, Aymard G, Cacoub P, Francès C, et al. 2006. “Low Blood Concentration of Hydroxychloroquine Is a Marker for and Predictor of Disease Exacerbations in Patients with Systemic Lupus Erythematosus.” Arthritis & Rheumatism 54 (10): 3284–90. doi:10.1002/art.22156.